AstraZeneca PLC Equity-NMS: AZN

$73.95 0.86 (August 4, 2025)

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$73.09
Open :$73.55
Today's high :$74.12
Today's low :$73.34
52W low :$61.24
52W high :$86.4638
EPS(TTM): :2.66
Shares O/S :3.1 B
Market cap :229.28 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of AstraZeneca PLC today?

AstraZeneca PLC (AZN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AstraZeneca PLC?

Yes, Indian Investors can invest in the AstraZeneca PLC (AZN) Share by opening an international trading account with Angel One.

How can I purchase AstraZeneca PLC shares in India?

Purchasing AstraZeneca PLC (AZN) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying AstraZeneca PLC (AZN) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AstraZeneca PLC?

Yes, you can purchase fractional shares of AstraZeneca PLC (AZN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AstraZeneca PLC?

The market capitalization of AstraZeneca PLC on January 1, 1970, is $0.

What documents are required to invest in AstraZeneca PLC stocks?

In order to invest in AstraZeneca PLC (AZN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About AstraZeneca PLC

AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. Its oncology candidate includes FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer, which is in a Phase II trial. It also discovers, develops, and manufactures T-cell receptor therapies. Its Eneboparatide is an investigational therapeutic peptide.